SAN DIEGO, Nov. 3, 2010 /PRNewswire/ — Aethlon Medical, Inc.
(OTC Bulletin Board:
AEMD), the pioneer in developing therapeutic filtration devices
to address infectious disease and cancer, disclosed today that it
will present tomorrow at the at the Singular Research Fifth Annual
“Best of the Uncovereds” Conference in Los Angeles.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
(Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
Jim Joyce, Aethlon’s Chairman & CEO, will present at 11:20
a.m. and during the remainder of the day, Mr. Joyce will meet with
investors during a series of one-on-one breakout meetings at the
conference. The conference (http://www.singularresearch.com/botu2010.htm)
is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.
Aethlon also disclosed that on Saturday, November 6, 2010, Jim
Frakes, Aethlon’s CFO, will present at RedChip’s Small-Cap Investor
Conference at Financial Fest 2010 in Phoenix, Arizona. The
conference (
http://www.redchip.com/visibility/conferencePages/Phoenix2010/conferenceMain.asp)
will be held at the Phoenix Convention Center.
About Aethlon MedicalAt Aethlon Medical, we create
revolutionary devices to address infectious disease and cancer. Our
devices are designed to be novel platform solutions that fill
therapeutic voids or aid in disease diagnosis and
monitoring.
Our Hemopurifier® is the first medical device to
selectively target the removal of infectious viruses and
immunosuppressive proteins from the entire circulatory
‘/>”/>
